Astrazeneca PLC (AZN): Price and Financial Metrics
Astrazeneca PLC (AZN)
Today's Latest Price: $47.33 USD
0.49 (-1.02%)
Updated Nov 14 11:38am
Add AZN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
AZN Stock Summary
- Astrazeneca Plc's market capitalization of $121,914,534,532 is ahead of 98.56% of US-listed equities.
- Price to trailing twelve month operating cash flow for AZN is currently 31.82, higher than 88.44% of US stocks with positive operating cash flow.
- As for revenue growth, note that AZN's revenue has grown -15.35% over the past 12 months; that beats the revenue growth of merely 11.25% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Astrazeneca Plc, a group of peers worth examining would be AMGN, TXN, LLY, PYPL, and SNY.
- Visit AZN's SEC page to see the company's official filings. To visit the company's web site, go to www.astrazeneca.com.
AZN Daily Price Range
AZN 52-Week Price Range
AZN Stock Price Chart More Charts
AZN Price/Volume Stats
| Current price | $47.33 |
| Prev. close | $47.82 |
| Day low | $47.11 |
| Day high | $47.51 |
| 50-day MA | $45.09 |
| 200-day MA | $41.90 |
| 52-week high | $49.22 |
| 52-week low | $35.30 |
| Volume | 501,642 |
| Avg. volume | 4,114,536 |
| Dividend yield | 1.84% |
| Market Cap | 124.18B |
Astrazeneca PLC (AZN) Company Bio
AstraZeneca plc engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. The company was founded in 1992 and is based in London, the United Kingdom.
Top Stories View All
Shares of Apple (AAPL) Hit All-Time Highs: Buy, Sell, or Hold?
Best & Worst Performing Stock Industries for November 13, 2019
Best & Worst Performing Small Cap Stocks for November 13, 2019
Best & Worst Performing Mid Cap Stocks for November 13, 2019
Best & Worst Performing Large Cap Stocks for November 13, 2019
View All Top Stories
Loading social stream, please wait...